Timing Is Everything: Combining Post-Transplantation Adoptive Cell Therapy and Tumor Vaccines.

about

Timing Is Everything: Combining Post-Transplantation Adoptive Cell Therapy and Tumor Vaccines.

Item

http://www.wikidata.org/entity/Q47147990

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Timing Is Everything: Combinin ...... ll Therapy and Tumor Vaccines.

@en

Timing Is Everything: Combinin ...... ll Therapy and Tumor Vaccines.

@nl

type

Item

label

Timing Is Everything: Combinin ...... ll Therapy and Tumor Vaccines.

@en

Timing Is Everything: Combinin ...... ll Therapy and Tumor Vaccines.

@nl

prefLabel

Timing Is Everything: Combinin ...... ll Therapy and Tumor Vaccines.

@en

Timing Is Everything: Combinin ...... ll Therapy and Tumor Vaccines.

@nl

P1476

Timing Is Everything: Combinin ...... ll Therapy and Tumor Vaccines.

@en

P2093

Miguel-Angel Perales

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus

Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.

Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemot

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.

Strategies to overcome immune ignorance and tolerance.

Enhanced responses to tumor immunization following total body irradiation are time-dependent

Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.

Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1.

Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.

P304

2113-2114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2016.10.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27721032

http://www.w3.org/2001/XMLSchema#string

P932

5568660

http://www.w3.org/2001/XMLSchema#string